Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery

被引:15
|
作者
Rader, Florian [1 ]
Pujara, Akshat C. [2 ]
Pattakos, Gregory [3 ]
Rajeswaran, Jeevanantham [4 ]
Li, Liang [4 ]
Castel, Laurie [5 ]
Chung, Mina K. [6 ]
Gillinov, A. Marc [3 ]
Costantini, Otto [7 ]
Van Wagoner, David R. [5 ,6 ]
Blackstone, Eugene H. [3 ,4 ]
机构
[1] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA
[2] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[3] Cleveland Clin, Inst Heart & Vasc, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44106 USA
[4] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA
[5] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44106 USA
[6] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44106 USA
[7] Case Western Reserve Univ, Heart & Vasc Ctr, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Atrial fibrillation; Postoperative; Biomarker; Ischemia; CABG; Valve surgery; ON-PUMP; CORONARY; ARRHYTHMIAS; RANOLAZINE; REVASCULARIZATION; PREDICTORS; AMIODARONE; PREVENTION; INFARCTION; BLOCKADE;
D O I
10.1016/j.hrthm.2012.10.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Postoperative atrial fibrillation (POAF) is common and associated with poor outcomes. Perioperative ischemia can alter arrhythmic substrate. OBJECTIVE To demonstrate an association between perioperative measurements of heart-type fatty acid binding protein (HT-FABP), a sensitive marker of ischemic myocardial injury. METHODS Blood samples from 63 inpatients undergoing coronary artery bypass surgery, valve surgery, or both were obtained before and up to 4 days after surgery. Continuous telemetry monitoring was used to detect POAF. Fifty-nine patients had at least 3 HT-FABP measurements. The relationship of enzyme-linked immunosorbent assay-measured HT-FABP with POAF was assessed by using joint logistic regression adjusted for age and surgery type. RESULTS Thirty-five patients (55%) developed POAF; these were, on average, order (69.3 +/- 10 years vs 60 +/- 11 years; P = .0019), with a higher prevalence of heart failure (43% vs 17%; P = .034), chronic obstructive lung disease (26% vs 4%; P = .017), preoperative calcium channel blocker use (29% vs 7%; P = .031), and more likely to undergo combined surgery (21% vs 11%, P = .049). The joint age- and coronary artery bypass surgery-adjusted model revealed that postoperative but not preoperative HT-FABP levels predicted POAF (coefficient 1.9 +/- 0.87; P = .03). longer bypass time, prior infarction, and worse renal function were all associated with higher postoperative HT-FABP. CONCLUSIONS A greater rise of HT-FABP is associated with atrial fibrillation after cardiac surgery, suggesting that ischemic myocardial damage is a contributing underlying mechanism. Interventions that decrease perioperative ischemic injury may also decrease the occurrence of POAF.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 50 条
  • [31] Heart-type Fatty Acid Binding Protein in the Assessment of Acute Pulmonary Embolism
    Qian, Hai-Yan
    Huang, Ji
    Yang, Yue-Jin
    Yang, Yan-Min
    Li, Zhi-Zhong
    Zhang, Jing-Mei
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 352 (06): : 557 - 562
  • [32] Measurement of Heart-Type Fatty Acid-Binding Protein Before Discharge
    Yamamoto, Takeshi
    Yasutake, Masahiro
    CIRCULATION JOURNAL, 2013, 77 (04) : 904 - 905
  • [33] Heart-type Fatty Acid Binding Protein as Predictor of Cardiac Mortality and Events in Patients with Acute Decompensated Heart Failure
    Ishino, Mitsunori
    Shishido, Tetsuro
    Funayama, Akira
    Netsu, Shunsuke
    Kiribayashi, Nobuyuki
    Arimoto, Takanori
    Takahashi, Hiroki
    Miyashita, Takehiko
    Miyamoto, Takuya
    Nitobe, Joji
    Watanabe, Tetsu
    Kubota, Isao
    CIRCULATION, 2010, 122 (21)
  • [34] Prognostic importance of elevated circulating levels of heart-type fatty acid binding protein in patients with congestive heart failure
    Arimoto, T
    Takeishi, Y
    Shiga, R
    Fukui, A
    Tachibana, H
    Nozaki, N
    Hirono, O
    Kubota, I
    EUROPEAN HEART JOURNAL, 2003, 24 : 60 - 60
  • [35] Heart-type fatty acid binding protein - involvement in growth inhibition and differentiation
    Borchers, T
    Hohoff, C
    Buhlmann, C
    Spener, F
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1997, 57 (01): : 77 - 84
  • [36] Neuropharmacological phenotype of mice lacking heart-type fatty acid binding protein
    Yamarrioto, Yui
    Motohashi, Keiju
    Shioda, Norifumi
    Owada, Yuji
    Fukunaga, Kohji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 109P - 109P
  • [37] Heart-type fatty acid binding protein level in familial Mediterranean fever
    Ariturk, Ozlem Karakurt
    Ureten, Kemal
    Sari, Munevver
    Yazihan, Nuray
    Yilmaz, Evin
    Erguder, Imge
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2013, 41 (01): : 38 - 44
  • [38] Comparison between creatine kinase MB, heart-type fatty acid-binding protein, and cardiac troponin T for detecting myocardial ischemic injury after cardiac surgery
    Jo, Min Seop
    Lee, Jehoon
    Kim, Soo-Young
    Kwon, Hi Jeong
    Lee, Hae Kyung
    Park, Dong Jin
    Kim, Yeongsic
    CLINICA CHIMICA ACTA, 2019, 488 : 174 - 178
  • [39] Heart-type Fatty Acid Binding Protein as an Adjunct to Cardiac Troponin-I for the Diagnosis of Myocardial Infarction
    Kim, Kyung Su
    Lee, Hui Jai
    Kim, Kyuseok
    Jo, You Hwan
    Kim, Tae Yun
    Lee, Jin Hee
    Rhee, Joong Eui
    Suh, Gil Joon
    Kim, Mi Ran
    Lee, Christopher C.
    Singer, Adam J.
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (01) : 47 - 52
  • [40] Human heart-type fatty acid-binding protein as an early diagnostic marker of doxorubicin cardiac toxicity
    Elghandour, A.
    Azab, S.
    El Rahaman, M. Abd
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 543 - 543